Table 1.
Clinical and biochemical characteristics of 107 MDS patients.
| MDS patients (n = 107) | |
|---|---|
| WBC(×109/L) | 2.7(0.6–9.4) |
| HB (g/dL) | 8.1(6.0–10.8) |
| PLT(×109/L) | 59(7–395) |
| ALT (IU/L) | 19(1–73) |
| AST(IU/L) | 20(1–71) |
| Creatinine (μmol/L) | 82(49–98) |
| CRP (mg/L) | 3.0(1.0–8.7) |
| Cytogenetics | |
| Low (N) | 59 |
| Intermediate (N) | 24 |
| High (N) | 15 |
| No data (N) | 9 |
| IPSS | |
| Low risk (N) | 8 |
| Int-1 (N) | 60 |
| Int-2 (N) | 24 |
| High (N) | 6 |
| No data (N) | 9 |
Abbreviations: WBC, white blood count; HB, hemoglobin; PLT, platelet level; ALT, Alanine Transaminase; AST, Aspartate Transaminase; CRP, C-reactive protein; IPSS, International Prognostic Scoring System.